[{"NetIncomeLoss_1_Q1_USD":-26411256.0,"AssetsCurrent_0_Q1_USD":1772996.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":302000.0,"PaymentsToAcquireInvestments_1_Q1_USD":276000000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-276000000.0,"OperatingCostsAndExpenses_1_Q1_USD":57619.0,"InterestIncomeOther_1_Q1_USD":2571.0,"CommitmentsAndContingencies_0_Q1_USD":null,"UnsecuredDebt_0_Q1_USD":300000.0,"PreferredStockSharesOutstanding_0_Q1_shares":null,"Liabilities_0_Q1_USD":52220665.0,"ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_1_Q1_USD":5520000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":1592055.0,"InvestmentIncomeNonoperating_1_Q1_USD":504743.0,"InterestAndDebtExpense_1_Q1_USD":100000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":277831753.0,"ProceedsFromIssuanceOfPrivatePlacement_1_Q1_USD":7520000.0,"AssetsHeldInTrustNoncurrent_0_Q1_USD":276002571.0,"FederalDepositInsuranceCorporationPremiumExpense_1_Q1_USD":250000.0,"BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_0_Q1_USD":15675247.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-1138.0,"AssetsFairValueDisclosure_0_Q1_USD":42258665.0,"PrepaidExpenseCurrent_0_Q1_USD":180941.0,"FairValueAdjustmentOfWarrants_1_Q1_USD":25851465.0,"StockIssuedDuringPeriodValueIssuedForServices_1_Q1_USD":251942296.0,"Assets_0_Q1_USD":277775567.0,"StockRedeemedOrCalledDuringPeriodValue_1_Q1_USD":-220554900.0,"PreferredStockSharesIssued_0_Q1_shares":null,"OtherUnderwritingExpense_1_Q1_USD":495247.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q1_USD":9.2,"AdditionalPaidInCapital_0_Q1_USD":31411152.0,"BusinessAcquisitionSharePrice_0_Q1_USD":9.2,"NonoperatingIncomeExpense_1_Q1_USD":-26353637.0,"LiabilitiesCurrent_0_Q1_USD":302000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-239698.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":1592055.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-26412394.0,"TemporaryEquityRedemptionPricePerShare_0_Q1_USD":18.0,"StockholdersEquity_0_Q1_USD":5000002.0,"DeferredOfferingCosts_0_Q1_USD":null,"Capital_0_Q1_USD":25000.0,"BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_0_Q1_pure":0.6,"PreferredStockSharesAuthorized_0_Q1_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":277775567.0,"PreferredStockValue_0_Q1_USD":null,"InvestmentIncomeInterest_1_Q1_USD":2571.0,"ProceedsFromIssuanceInitialPublicOffering_1_Q1_USD":270480000.0,"OperatingIncomeLoss_1_Q1_USD":-57619.0,"AssetsHeldInTrustCurrent_0_Q1_USD":276002571.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"IncreaseDecreaseInPrepaidExpense_1_Q1_USD":180941.0,"ClassOfWarrantOrRightOutstanding_0_Q1_shares":166666.0,"Ticker":"SLGC","CIK":"1837412","name":"CM LIFE SCIENCES II INC.","OfficialName":"SomaLogic Inc. Class A Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1247459487.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20210524"}]